BlossomHill Therapeutics, Inc. Common Stock (BLSM) — Financial Flexibility Index
BlossomHill Therapeutics, Inc. Common Stock (BLSM) has a Financial Flexibility Index of -0.07x as of March 2026. Free cash flow of $-20.93 Million (operating CF $-20.94 Million minus capex $13.00K) represents 0% of total liabilities ($295.53 Million). Also explore BLSM shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BlossomHill Therapeutics, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for BlossomHill Therapeutics, Inc. Common Stock across 2 annual periods. For the full cash flow conversion analysis, see BlossomHill Therapeutics, Inc. Common St operating cash flow efficiency.
Annual Financial Flexibility Index for BlossomHill Therapeutics, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for BlossomHill Therapeutics, Inc. Common Stock. Explore how well can BlossomHill Therapeutics, Inc. Common St service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.16x | $-45.86 Million | $-46.92 Million | $294.70 Million | ▲ +10.7% |
| 2024 | -0.17x | $-31.32 Million | $-31.42 Million | $179.66 Million | — |